Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Novel TNF-alpha antagonists synthesized at Bristol-Myers Squibb

Feb. 21, 2017

Merck KGaA compares MSB-11022 to Humira in phase III trial for rheumatoid arthritis

Feb. 21, 2017

Taiho Pharmaceutical discovers JAK3 inhibitors

Feb. 16, 2017

European Commission approves Olumiant for rheumatoid arthritis

Feb. 14, 2017

Can-Fite Biopharma set to begin phase III ACRobat study of piclidenoson

Feb. 9, 2017

Flexion Therapeutics' Zilretta NDA accepted for review by FDA

Feb. 8, 2017

Takeda discovers prostanoid EP4 receptor antagonists

Feb. 7, 2017

Institute of Experimental Botany identifies apoptosis inducers/ROS inhibitors

Feb. 7, 2017

Seikagaku initiates phase III study of SI-613 to treat osteoarthritis in Japan

Feb. 6, 2017

Canada first to approve Kevzara

Feb. 1, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...